Evolución y salud: evolución experimental y epidemiología
EVOSALUD
![Foto de Evolución y salud: evolución experimental y epidemiología](/img/grupo.png)
![Foto de Fundación Jiménez Díaz](/img/noimage_org.png)
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (12)
2019
-
Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count
Journal of Microbiology, Immunology and Infection, Vol. 52, Núm. 4, pp. 667-671
2018
-
Role of APOBEC3H in the viral control of HIV elite controller patients
International Journal of Medical Sciences, Vol. 15, Núm. 2, pp. 95-100
2017
-
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
2016
-
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9
-
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Journal of Infection, Vol. 71, Núm. 3, pp. 385-394
-
Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10
2014
-
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 20, Núm. 4
2011
-
Molecular surveillance of HIV-1 in Madrid, Spain: A phylogeographic analysis
Journal of Virology, Vol. 85, Núm. 20, pp. 10755-10763
2003
-
Pseudomonas aeruginosa: Estudio multicéntrico en 136 hospitales Españoles
Revista Espanola de Quimioterapia, Vol. 16, Núm. 1, pp. 41-52
2002
-
Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]
Journal of Antimicrobial Chemotherapy